SEC Form 4 · accession 0001144204-16-115795
China Biologic Products, Inc. · CBPO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Hui Li
Director
Period of report
Jul 1, 2016
Accepted (ET)
Aug 2, 2016 · 6:49 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001369868
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Restricted StockF1 | Jul 1, 2016 | A | 15,000 | $0.00 | A | 20,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the grant of restricted stock to the Reporting Person under the Issuer's 2008 equity incentive plan, pursuant to a restricted stock grant agreement dated July 1, 2016 (the "Restricted Stock Agreement"). The restricted stock will vest and the Issuer's right to reacquire the restricted stock will lapse over a three-year period in three equal portions, with an initial vesting date on July 2, 2017, provided that the Reporting Person has been continuously a Service Provider (as defined in the Restricted Stock Agreement) from July 1, 2016 until the date such vesting occurs.
Remarks
* This Form 4 is filed late due to administrative oversight.